Related Experiment Videos
Effects of alcohol on platelet functions
1INSERM, Unit 330, Bordeaux, France.
Summary
Moderate alcohol intake may protect against heart disease and stroke. However, binge drinking can increase clotting risk, a rebound effect not seen with moderate red wine consumption.
Area of Science:
- Cardiovascular Science
- Pharmacology
Background:
- Epidemiologic studies suggest moderate alcohol intake protects against coronary heart disease and ischemic stroke.
- Alcohol consumption may increase the risk of cerebral hemorrhage.
- Alcohol's effect on platelets resembles aspirin's, influencing aggregation responses.
Purpose of the Study:
- To investigate the immediate and delayed effects of alcohol on platelet aggregation.
- To explore the potential mechanisms behind alcohol's cardiovascular effects, including the 'rebound phenomenon'.
- To compare the effects of red wine and spirits on platelet function and lipid peroxidation.
Main Methods:
- In vitro and in vivo studies on human and animal platelet aggregation.
- Analysis of platelet aggregation in response to various agonists (thrombin, ADP, epinephrine, collagen).
- Assessment of lipid peroxidation markers (conjugated dienes) in relation to alcohol consumption.
Main Results:
- Alcohol acutely decreases platelet aggregation, but a rebound increase in aggregation, particularly to thrombin, occurs hours later or after withdrawal.
- This rebound phenomenon, observed in binge drinkers and alcoholics, may explain increased ischemic events.
- Moderate red wine consumption did not show the rebound effect; grape tannins in wine reduced lipid peroxidation, unlike spirits.
Conclusions:
- Alcohol's effect on platelet aggregation is complex, with potential risks associated with binge drinking due to a rebound hyper-aggregative state.
- Moderate red wine consumption may offer cardiovascular protection by mitigating alcohol-induced platelet rebound and reducing lipid peroxidation.
- Further research is needed to fully understand the role of lipid peroxides in alcohol-related platelet reactivity and cardiovascular outcomes.